SCOPUS 정보 검색 플랫폼

Volumn 32, Issue 3, 2001, Pages 396-401

Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix

(8) Connor, Bradley A a Phair, John b Sack, David c McEniry, David d Hornick, Richard e Banerjee, Dalfoni f Jensen, Erin f Kuter, Barbara f

a WEILL CORNELL MEDICAL COLLEGE (United States)

b NORTHWESTERN UNIVERSITY (United States)

c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH (United States)

d Infections Limited (United States)

e ORLANDO HEALTH (United States)

f MERCK RESEARCH LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HEPATITIS A; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INJECTION PAIN; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATOVIRUS; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; TIME FACTORS; VACCINES, INACTIVATED;

EID: 0035109802 PISSN: 10584838 EISSN: None Source Type: Journal
DOI: 10.1086/318522 Document Type: Article

Times cited : (22)

References (18)

1
- 0005910978
- (1998) Physicians Desk Reference. US package circular for Vaqta

2
- 0005910978
- (1998) Physicians Desk Reference. US package circular for Havrix

3
- 0002049066
- Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease: proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: contemporary issues and future prospects. Baltimore: Williams and Wilkins
- (1991) Use of a live, attenuated hepatitis A vaccine to prepare a highly purified formalin-inactivated hepatitis A vaccine , pp. 94-97
- Lewis, J.A.¹ Armstrong, M.E.² Larson, V.M.³

4
- 0027717602
- Development of the formalin-inactivated hepatitis A vaccine Vaqta from the live attenuated virus strain CR326F
- (1993) J Hepatol , vol.18 , pp. S20-S26
- Armstrong, M.E.¹ Giesa, P.A.² Davide, J.P.³

5
- 0028944928
- Approaches to a vaccine against hepatitis A: Development and manufacture of an inactivated vaccine
- (1995) J Infect Dis , vol.171 , pp. S33-S39
- Andre, F.E.¹

6
- 0026643021
- A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
- (1992) N Engl J Med , vol.327 , pp. 453-457
- Werzberger, A.¹ Mensch, B.² Kuter, B.³

7
- 0028900520
- Vaqta, hepatitis A vaccine, purified inactivated
- (1995) Drug Future , vol.20 , pp. 24-29
- Nalin, D.¹

8
- 0028265277
- Protection against hepatitis A by an inactivated vaccine
- (1994) JAMA , vol.271 , pp. 1328-1334
- Innis, B.L.¹ Snitbhan, R.² Kunasol, P.³

9
- 0028928908
- Clinical experience with an inactivated hepatitis A vaccine
- (1995) J Infect Dis , vol.171 , pp. S44-S49
- Clemens, R.¹ Safary, A.² Hepburn, A.³

10
- 84983702173
- A comparison of the composition of adult doses of Vaqta and Havrix
- (1996) JAMA , vol.276 , pp. 450
- Nalin, D.¹

11
- 0027378137
- Sensitive assays for hepatitis A antibodies
- (1993) J Med Virol , vol.41 , pp. 201-204
- Miller, W.J.¹ Clark, W.² Hurni, W.³ Kuter, B.⁴ Schofield, T.⁵ Nalin, D.⁶

12
- 0025633361
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero difference or non-unity relative risk
- (1990) Stat Med , vol.9 , pp. 1447-1454
- Farrington, C.P.¹ Manning, G.²

13
- 0004245434
- Edinburgh: Oliver and Boyd
- (1935) The design of experiment
- Fisher, R.A.¹

14
- 0033597240
- Comparative immunogenicity and tolerance of Vaqta and Havrix
- (1999) Vaccine , vol.17 , pp. 2181-2184
- Braconier, J.H.¹ Wennerholm, S.² Norrby, S.R.³

15
- 0005948661
- Measuring injection site pain associated with vaccine administration: A randomized double-blind placebo-controlled clinical trial
- in press
- J Epidemiol Biostatistics
- Su, L.¹ Tucker, R.² Frey, S.³

16
- 0005911962
- Retrospective evaluation to assess the boosting effect of Vaqta following a single dose of Havrix
- Phoenix, AZ, 20 October
- (1998) Abstracts of the American College of Environmental Medicine
- Kuter, B.J.¹ Hackett, C.M.²

17
- 0005942947
- A comparison of immunogenicity and safety following the use of Avaxim or Havrix 1440 as a booster for subjects primed 6 months previously with Havrix 1440
- 24-27 March
- (1997) Proceedings and abstracts of the 5th International Conference on Travel Medicine (Geneva)
- Zuckerman, J.¹ Huang, M.²

18
- 0033553284
- Combination vaccines for childhood immunization
- (1999) MMWR Morb Mortal Wkly Rep , vol.48 , Issue.RR4 , pp. 1-14

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.